Analysen von Keyur Parekh
| 18.07.14 | GSK Neutral | Goldman Sachs Group Inc. | |
| 15.07.14 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
| 15.07.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 05.06.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 14.05.14 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.05.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 16.04.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.04.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
| 01.07.10 | AstraZeneca halten | Goldman Sachs Group Inc. | |